Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C14H21N3O3S |
| Molecular Weight | 311.4 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1=CC=C(C=C1N)S(=O)(=O)NC(=O)NC2CCCCC2
InChI
InChIKey=XXYTXQGCRQLRHA-UHFFFAOYSA-N
InChI=1S/C14H21N3O3S/c1-10-7-8-12(9-13(10)15)21(19,20)17-14(18)16-11-5-3-2-4-6-11/h7-9,11H,2-6,15H2,1H3,(H2,16,17,18)
| Molecular Formula | C14H21N3O3S |
| Molecular Weight | 311.4 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Metahexamide (N(3-amino-4-methyl-benzenesulfonyl)-N'-cyclohexylurea) is an oral hypoglycemizing agent. The remarkable hypoglycemizing action of metahexamide is justified by two properties: the slow metabolism and the strongly enhanced peripheral glucose utilization. Metahexamide has been studied in the treatment of diabetes.
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Apr 02 08:45:27 GMT 2025
by
admin
on
Wed Apr 02 08:45:27 GMT 2025
|
| Record UNII |
T3U6F5D722
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C97936
Created by
admin on Wed Apr 02 08:45:27 GMT 2025 , Edited by admin on Wed Apr 02 08:45:27 GMT 2025
|
||
|
WHO-ATC |
A10BB10
Created by
admin on Wed Apr 02 08:45:27 GMT 2025 , Edited by admin on Wed Apr 02 08:45:27 GMT 2025
|
||
|
WHO-VATC |
QA10BB10
Created by
admin on Wed Apr 02 08:45:27 GMT 2025 , Edited by admin on Wed Apr 02 08:45:27 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
1717
Created by
admin on Wed Apr 02 08:45:27 GMT 2025 , Edited by admin on Wed Apr 02 08:45:27 GMT 2025
|
PRIMARY | |||
|
863
Created by
admin on Wed Apr 02 08:45:27 GMT 2025 , Edited by admin on Wed Apr 02 08:45:27 GMT 2025
|
PRIMARY | |||
|
CHEMBL507419
Created by
admin on Wed Apr 02 08:45:27 GMT 2025 , Edited by admin on Wed Apr 02 08:45:27 GMT 2025
|
PRIMARY | |||
|
SUB08803MIG
Created by
admin on Wed Apr 02 08:45:27 GMT 2025 , Edited by admin on Wed Apr 02 08:45:27 GMT 2025
|
PRIMARY | |||
|
METAHEXAMIDE
Created by
admin on Wed Apr 02 08:45:27 GMT 2025 , Edited by admin on Wed Apr 02 08:45:27 GMT 2025
|
PRIMARY | |||
|
C100077
Created by
admin on Wed Apr 02 08:45:27 GMT 2025 , Edited by admin on Wed Apr 02 08:45:27 GMT 2025
|
PRIMARY | |||
|
DTXSID3023267
Created by
admin on Wed Apr 02 08:45:27 GMT 2025 , Edited by admin on Wed Apr 02 08:45:27 GMT 2025
|
PRIMARY | |||
|
C91022
Created by
admin on Wed Apr 02 08:45:27 GMT 2025 , Edited by admin on Wed Apr 02 08:45:27 GMT 2025
|
PRIMARY | |||
|
11259
Created by
admin on Wed Apr 02 08:45:27 GMT 2025 , Edited by admin on Wed Apr 02 08:45:27 GMT 2025
|
PRIMARY | |||
|
100000081193
Created by
admin on Wed Apr 02 08:45:27 GMT 2025 , Edited by admin on Wed Apr 02 08:45:27 GMT 2025
|
PRIMARY | |||
|
T3U6F5D722
Created by
admin on Wed Apr 02 08:45:27 GMT 2025 , Edited by admin on Wed Apr 02 08:45:27 GMT 2025
|
PRIMARY | |||
|
DB13675
Created by
admin on Wed Apr 02 08:45:27 GMT 2025 , Edited by admin on Wed Apr 02 08:45:27 GMT 2025
|
PRIMARY | |||
|
209-276-9
Created by
admin on Wed Apr 02 08:45:27 GMT 2025 , Edited by admin on Wed Apr 02 08:45:27 GMT 2025
|
PRIMARY | |||
|
565-33-3
Created by
admin on Wed Apr 02 08:45:27 GMT 2025 , Edited by admin on Wed Apr 02 08:45:27 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
